---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-25-000164"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T16:48:43.549931+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Chemed projects $18-25M Medicare Cap hit; lowers FY2025 guidance

## Summary
- VITAS expects $18M-$25M Medicare Cap revenue limit for Florida consolidated program (excl. Tallahassee) in 2025 Cap Year.
- Lower-than-expected Medicare admissions in Apr-May 2025 and rate differential (2.9% cap increase vs 5.2% reimbursement) caused the cap.
- Roto-Rooter experienced unexpected residential demand weakness in Q2 2025; commercial improvement insufficient to offset.
- VITAS received Florida CON for Pinellas County on June 20, aiding growth and Cap mitigation for 2026.
- Full Q2 2025 results and revised FY2025 guidance due July 29; conference call July 30.

## SEC filing metadata
- accession: 0001562762-25-000164
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000156276225000164/0001562762-25-000164-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000156276225000164/che-20250627x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-25-000164
- JSON: https://secwatch.observer/filing/0001562762-25-000164.json
- Plain text: https://secwatch.observer/filing/0001562762-25-000164.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.